Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103385 · ClinicalTrials.gov registry record · NA
Reconnecting: Improving Interoception to Reduce Suicidal Ideation in the Military
A NA study of Suicidal Ideation and Interoception, sponsored by Miami University.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
- 2
- Study locations
NCT04103385 is a NA study of Suicidal Ideation and Interoception that has completed, run by Miami University. The registered enrollment target is 195 participants, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (27% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04103385, a NA study of Suicidal Ideation and Interoception, has completed, sponsored by Miami University.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: Interoception is defined as the "sense of the physiological condition of the entire body" and is crucial for recognizing emotions and sensations (e.g., hunger, temperature, pain) and responding accordingly. The investigator's lab has conducted several independent studies and two pilot studies that support the hypothesis that disrupted interoception leads one to be disconnected from the body, and thus more able to harm the body should one desire to do so. Research suggests that interoceptive deficits may not only differentiate those who are thinking about suicide from those who engage in suicidal behavior, but it may also provide information about who is at imminent risk for suicidal behavior. The identification of novel, short-term risk factors, like interoceptive deficits, allows for the development of new treatment applications for suicide, which is important for several reasons: 1) suicide rates have increased in recent years, especially among military populations, and 2) existing treatment approaches are often ineffective, lengthy, expensive, or impractical for large-scale dissemination. This project evaluates a novel, brief intervention for interoceptive deficits and suicidal behavior with the potential to be acceptable and feasible for a military population.
Conditions Studied
Interventions
- BEHAVIORAL RISE (Reconnecting to Internal Sensations and Experiences)
- BEHAVIORAL RISE (Reconnecting to Individual Strength and Energy)
Study Locations (2)
Ohio
- Wright Patterson Medical Center - Dayton
Washington
- Madigan Army Medical Center - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04103385
The ClinicalTrials.gov registry entry for NCT04103385 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (27% lower). The listed sponsor is Miami University, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which RISE (Reconnecting to Internal Sensations and Experiences) is the first listed.
NCT04103385 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Washington.
Frequently Asked Questions
What is clinical trial NCT04103385 about?
NCT04103385 is a clinical study titled "Reconnecting: Improving Interoception to Reduce Suicidal Ideation in the Military". Background: Interoception is defined as the "sense of the physiological condition of the entire body" and is crucial for recognizing emotions and sensations (e.g., hunger, temperature, pain) and responding accordingly. The investigator's lab has conducted several independent studies and two pilot st...
What is the current status of trial NCT04103385?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2020-06-01. Estimated completion is 2021-11-22.
What conditions does trial NCT04103385 study?
This clinical trial studies the following conditions: Suicidal Ideation, Interoception.
What interventions are being tested in trial NCT04103385?
The interventions under investigation include: RISE (Reconnecting to Internal Sensations and Experiences) (BEHAVIORAL), RISE (Reconnecting to Individual Strength and Energy) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04103385?
This trial is sponsored by Miami University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04103385 being conducted?
This trial has 2 study locations across Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.